---
figid: PMC7401253__marinedrugs-18-00347-g005
figtitle: Scheme highlighting the pathophysiology of neurodegenerative disorders and
  post-ischemic consequences along with indicating the underlying mechanism of neuroprotective
  action of algal compounds
organisms:
- PX clade
- Haematococcus lacustris
- Saccharina japonica
- Undaria pinnatifida
- Pinus pinaster
- Neopyropia yezoensis
- Fucus vesiculosus
- Ecklonia cava
- Nannochloropsis oculata
- Sargassum fusiforme
- Botryococcus braunii
- Eisenia bicyclis
- Sargassum binderi
- Ishige okamurae
- Sargassum polycystum
- Ulva prolifera
- Neoporphyra haitanensis
- Sargassum siliquastrum
- Sargassum swartzii
- Padina pavonica
- Ulva lactuca
- Ecklonia maxima
- Sargassum horneri
- Kappaphycus alvarezii
- Bifurcaria bifurcata
- Gelidium amansii
- Sargassum horridum
- Capsosiphon fulvescens
- Gracilaria corticata
- Sargassum muticum
- Caulerpa racemosa
- Sargassum hemiphyllum
- Laurencia obtusa
- Padina australis
- Sargassum serratifolium
- Hypnea musciformis
- Gracilariopsis chorda
- Silvetia siliquosa
- Gelidium foliaceum
- Sargassum sagamianum
- Sargassum crassifolium
- Gracilaria gracilis
- Padina gymnospora
- Ishige foliacea
- Ulva compressa
- Lithothamnion corallioides
- Dictyopteris undulata
- Gelidiella acerosa
- Sargassum fulvellum
- Saccorhiza polyschides
- Codium tomentosum
- Myagropsis myagroides
- Sargassum micracanthum
- Halimeda cuneata
- Macrocystis angustifolia
- Asparagopsis taxiformis
- Cladophora prolifera
- Symphyocladia latiuscula
- Codium duthieae
- Sargassum macrocarpum
- Gongolaria nodicaulis
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Caenorhabditis elegans
- Limnospira maxima
- NA
- NA
pmcid: PMC7401253
filename: marinedrugs-18-00347-g005.jpg
figlink: pmc/articles/PMC7401253/figure/marinedrugs-18-00347-f005/
number: F5
caption: A scheme highlighting the pathophysiology of neurodegenerative disorders
  and post-ischemic consequences along with indicating the underlying mechanism of
  neuroprotective action of algal compounds. The numeric symbols indicate the points
  of pharmacological action that include (1) inhibition of cytokine secretion from
  activated microglia by fucoxanthin, fucosterol, fucoidan, dieckol, phlorofucofuroeckol
  and bieckol, κ-carrageenan, floridoside and seleno-polymannarate, (2) attenuation
  of inflammatory response via inhibition of NF-κB pathway by eckol, dieckol and 8,8-bieckol,
  (3) priming of antioxidant defense system via activation of Nrf2/ARE pathway (blocking
  interaction between Nrf2 and Keap1) by fucoxanthin, fucoidan and zonarol, (4) Reduction
  of apoptosis via inhibiting pro-apoptotic JNK/Erk pathway by dimethylsulfoniopropionate
  and κ-carrageenan-derived pentasaccharide, (5) Inhibition of glutamate-induced Ca2+
  influx via blocking extrasynaptic GluN2B by fucoidan and tramiprosate, (6) Activation
  of BDNF-dependent pro-survival pathway via inducing PI3K/Akt or TrkB/ERK signaling
  by fucoxanthin and fucosterol, (7) Attenuation of I/R-injury via preventing excitotoxic
  depolarization by C-phycocyanin, (8) Inhibition of nNOS sequestration by tramiprosate,
  (9) proteasomal degradation by fucoidan, (10) Induction of autophagy/mitophagy by
  fucoxanthin, (11) anticholinesterase activity by fucoidan, fucoxanthin, dieckol
  and phlorofucofuroeckol, (12) anti-amyloidogenesis via blocking β-secretase activity
  by fucoxanthin, fucosterol and glycoprotein, and (13) Aβ-clearance via enhancing
  the transcription of ApoE and ABC transporters genes by fucosterol, saringasterol,
  and alginate-derived oligosaccharide. NF-κB/p50-pp65, nuclear factor kappa-light-chain-enhancer
  of activated B cells; Nrf2, nuclear factor erythroid 2-related factor 2; ARE, antioxidant
  response element; IkB, inhibitor of NF-κB; Keap1, Kelch-like ECH-associated protein
  1; JNK, c-Jun N-terminal kinases; GluN2B, N-methyl D-aspartate receptor subtype
  2B; PI3K, phosphoinositide 3-kinases; Akt, protein kinase B; MEK1/2, mitogen-activated
  protein kinase kinase; ERK, extracellular signal-regulated kinases; TrkB, tropomyosin
  receptor kinase B; CREB, cAMP-response element binding protein; CRE, cAMP response
  elements; BDNF, Brain-derived neurotrophic factor; AChE, acetylcholinesterase; Ach,
  acetylcholine; ABCA1, ATP-binding cassette transporter A1; nNOS, neuronal nitric
  oxide synthase; ROS, reactive oxygen species; ψ, mitochondrial membrane potential.
papertitle: 'Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites:
  Pharmacological Insights and Therapeutic Advances.'
reftext: Md. Abdul Hannan, et al. Mar Drugs. 2020 Jul;18(7):347.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9569842
figid_alias: PMC7401253__F5
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC7401253__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7401253__marinedrugs-18-00347-g005.html
  '@type': Dataset
  description: A scheme highlighting the pathophysiology of neurodegenerative disorders
    and post-ischemic consequences along with indicating the underlying mechanism
    of neuroprotective action of algal compounds. The numeric symbols indicate the
    points of pharmacological action that include (1) inhibition of cytokine secretion
    from activated microglia by fucoxanthin, fucosterol, fucoidan, dieckol, phlorofucofuroeckol
    and bieckol, κ-carrageenan, floridoside and seleno-polymannarate, (2) attenuation
    of inflammatory response via inhibition of NF-κB pathway by eckol, dieckol and
    8,8-bieckol, (3) priming of antioxidant defense system via activation of Nrf2/ARE
    pathway (blocking interaction between Nrf2 and Keap1) by fucoxanthin, fucoidan
    and zonarol, (4) Reduction of apoptosis via inhibiting pro-apoptotic JNK/Erk pathway
    by dimethylsulfoniopropionate and κ-carrageenan-derived pentasaccharide, (5) Inhibition
    of glutamate-induced Ca2+ influx via blocking extrasynaptic GluN2B by fucoidan
    and tramiprosate, (6) Activation of BDNF-dependent pro-survival pathway via inducing
    PI3K/Akt or TrkB/ERK signaling by fucoxanthin and fucosterol, (7) Attenuation
    of I/R-injury via preventing excitotoxic depolarization by C-phycocyanin, (8)
    Inhibition of nNOS sequestration by tramiprosate, (9) proteasomal degradation
    by fucoidan, (10) Induction of autophagy/mitophagy by fucoxanthin, (11) anticholinesterase
    activity by fucoidan, fucoxanthin, dieckol and phlorofucofuroeckol, (12) anti-amyloidogenesis
    via blocking β-secretase activity by fucoxanthin, fucosterol and glycoprotein,
    and (13) Aβ-clearance via enhancing the transcription of ApoE and ABC transporters
    genes by fucosterol, saringasterol, and alginate-derived oligosaccharide. NF-κB/p50-pp65,
    nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf2, nuclear
    factor erythroid 2-related factor 2; ARE, antioxidant response element; IkB, inhibitor
    of NF-κB; Keap1, Kelch-like ECH-associated protein 1; JNK, c-Jun N-terminal kinases;
    GluN2B, N-methyl D-aspartate receptor subtype 2B; PI3K, phosphoinositide 3-kinases;
    Akt, protein kinase B; MEK1/2, mitogen-activated protein kinase kinase; ERK, extracellular
    signal-regulated kinases; TrkB, tropomyosin receptor kinase B; CREB, cAMP-response
    element binding protein; CRE, cAMP response elements; BDNF, Brain-derived neurotrophic
    factor; AChE, acetylcholinesterase; Ach, acetylcholine; ABCA1, ATP-binding cassette
    transporter A1; nNOS, neuronal nitric oxide synthase; ROS, reactive oxygen species;
    ψ, mitochondrial membrane potential.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nos1
  - Sdtq10
  - Tnf
  - App
  - H2-Ab1
  - Ache
  - Apoe
  - Tnfrsf1a
  - Ikbkg
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Akt1
  - Ephb2
  - Mapk1
  - Hmox1
  - Prdx6
  - Gpx1
  - Gpx3
  - Alpha-re
  - Il18
  - Bdnf
  - Ad
  - Pd
  - NOS1
  - NOS2
  - NOS3
  - RPL17
  - TPGS2
  - IGKV2D-14
  - TNF
  - APP
  - SUCLA2
  - FGFR3
  - ACHE
  - APOE
  - SYNE1
  - TAB1
  - TAB2
  - TAB3
  - TNFRSF1A
  - PSMD2
  - HSP90B3P
  - IKBKG
  - ATP8A2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - HMOX1
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - SOD1
  - SOD2
  - SOD3
  - IL18
  - BDNF
  - BDNF-AS
  - Syt1
  - Pik3cg
  - Ephb1
  - Acetate
  - Choline
  - Glutamate
  - NMDA
  - ATP
  - NO01
  - Jschamiarupurtfusion  injury  Excitetoxic
  - Neurodegenerative Disorders
  - AD
  - PD
---
